A Phase 2 Evaluation of the Monoclonal Antibody RAV12, i

Project: Research project

Project Details

Description

A Phase 2 Evaluation of the Monoclonal Antibody RAV12, in Combination with Standard Gemcitabine in the Treatment of Patients with Metastatic Pancreatic Cancer
StatusFinished
Effective start/end date9/3/0710/15/08

Funding

  • TGEN DRUG DEV SVC (TD2)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.